Scientific & Effective - yet Languishing Cancer Therapy
This effective, non-surgical, non-toxic and scientific cancer treatment has been languishing for more than 25 years, simply because it is dirt-cheap and not patentable. The sad truth is that healing cancer patients is a secondary concern for cancer institutions; the primary purpose is to make a profit or a living.
This cancer therapy is based on blocking a critical enzyme in DNA synthesis as well as in cell growth, Ribonucleotide Reductase (RnR), which converts building blocks of RNA into DNA. The activiity of this enzyme is most closely associated, by far, with cancerous growth, as shown in the table below:
The free-radical (unpaired electron) at the active-site of the enzyme RnR can be quenched (paired-up) by a stream of electrons or low-level electric current. Thus gentle electrotherapy would disable the enzyme RnR and arrest cancer growth. Alas, this therapy would cripple the cash flow of cancer institutions; hence they won't touch it!
The two scientific publications, in 1997 and 2014, describe the theoretical basis of this (GEIPE) cancer treatment along with ample supporting experimental evidence, with both animals and humans:
The latest published scientific article on the subject is a review:
Validation by Top Cancer Institutions
Top research institutions like National Cancer Institute and MD Anderson Cancer Center, Houston have acknowledged the validity of this approach to treat cancer. See this letter from June 1994:
It stated: "...the [electrotherapy] information are interesting and deserving of further investigation." ..."We will keep the material on file should opportunities arise to study the effects of electric currents on regression of tumors."
That "opportunity" has not come in more than 25 years, though funds needed to explore electrotherapy would be miniscule. (We have repeatedly written to hundreds of cancer institutions around the world including Memorial Sloan Kettering Cancer, Mayo Cancer Center and Dana-Farber Cancer Institute; MD Anderson Cancer Center was one of the very few that responded.)
The status quo is lucrative to many; oncologists giving chemotherpy or radiation treatments want to protect their jobs.
Scientific Proof of Efficacy of This Treatment
The very first cancer electrotherapy study was published in 1959 in journal 'Science'. In it, two Johns Hopkins scientists reported "total regression" of tumor in 60% of mice, which was highly remarkable for a maiden study.
Mysteriously, no follow up studies were done.
In 1985, a study published in preeminent journal 'Cancer Research' reported up to 98% tumor-shrinkage - virtual cure - after only 5 hours of gentle electrotherapy over 5 days.
Despite such positive results, further funding was denied. Please see 1995 letter of the lead author to me:
Together, we applied for a grant from CapCure but were declined.
Help of National Cancer Institute; Inaction by City of Hope
In 1994, National Cancer Institute found my ideas "very interesting" and referred me to Dr. Chou of City of Hope Medical Center (near LA) who was working with electric currents.
His colleague Dr. Y. Yen - PhD and MD, who had just moved from Yale -- happened to be working with the enzyme RnR. He fully agreed with my premise. But City of Hope management nixed the collaboration, as the therapy would not bring [moneyed] patients.
Dr. Y. Yen continued to work on the enzyme RnR, publishing dozens of papers -- and touting its inhibition an important objective in anti-cancer chemotherapeutic drug design.
Such chemo drugs have limited effectiveness and high toxicity. Dr. Yen DOES NOT MENTION that the enzyme RnR can be easily disabled - in non-toxic manner - by mild electric current.
He recently became president of Taipei Medical University, Taiwan. In May 2016, I sent him my two publications, and implored him to explore and standardize the therapy. He was "glad to know your good progress..." but claimed "I moved to Taiwan and no longer work on this project."
How? In 2016, he published at least two papers on enzyme RnR. The Taipei Medical University has a large "Center for Cancer Research" with 25+ scientists, including Dr. Yun Yen. Do cancer researchers not work on finding better treatments? Otherwise WHAT DO THEY DO?
India's top Cancer Hospital showed interest, then balked - twice
When the 1997 scientific publication about this novel cancer therapy was sent to over 300 cancer institutions in the world, only Tata Memorial Hospital, Mumbai -- India's top cancer institution -- showed interest in exploring this treatment further. See their letter:
However, within a year, during the making of suitable equipment, the hospital lost interest.
In 2010, after this treatment was successfully able to treat cancer of two human patients, Tata Memorial Hospital was contacted for the 2nd time. They responded again. (They must be highly praised for this since other cancer institutions of the world kept quiet.) The director of the hospital, Dr. Anil K. D'Cruz, started exchanging emails with me. I answered his various questions. Then suddenly he stopped the communication. I sent 9 emails, he sent 7. These emails can be seen at the link below:
Obviously the hospital sees potential in this cancer therapy, but is hesitant to take such a major step that would turn the most expensive treatment into least expensive. No hospital wants its income to go down...
Universality of GEIPE Cancer Treatment
This cancer therapy should be applicable to all cancers since malignant cells in any tissue need to synthesize their DNA to grow. At molecular level, cancer is a single disease!
We offer our GEIPE device for only visible/palpable cancers, simply because they can be treated as a home-remedy, without any assistance from a medical professional. Otherwise, the principle of GEIPE treatment (use of gentle electricity) is universally applicable, as shown by the following examples.
●► Two news items from mid-2022 about treating prostate cancer provide validation:
From the OregonLive in USA:
Surgical innovation uses electrical pulses to beat prostate cancer, technique called 'game-changer'
From the Telegraph in UK:
One-hour operation could cure prostate cancer by destroying tumours with electric currents
●► Already in use to treat brain and spinal cord tumors:
See this link in Nature journal:
FDA Approves New Electrical Fields Device for Brain Tumor Treatment
And, this link at cancer.org
Alternating Electric Field Therapy for Adult Brain & Spinal Cord Tumors
●► Proven effective for leukemia using The Kanzius Machine:
The esteemed newsmagazine "60 Minutes" of CBS has broadcast two episodes on The Kanzius Machine for treating cancer.
A radio engineer John Kanzius, suffering from leukemia,
built a machine that uses radio waves to produce a stream
of electrons (RF current) as indicated by lighting-up of a
florescent tube put in the path. Both he and Dr. S. Curley
of MD Anderson Cancer Center initially thought that RF
current/energy of the machine would heat metal
nanoparticle embedded in cancer, and thus cook/destroy
However, in desperation, Mr. Kanzius started treating himself with just RF current, without any metal; lo and behold, his leukemia started receding. (Unbeknownst to him, most likely he was blocking the enzyme RnR thereby destroying cancer.) Mr. Kanzius was almost completely healed but unfortunately, he was made to go thru an intense chemo regime. The toxicity of the drug, according to Dr. Curley, killed him.
Dr. S. Curley kept doing studies with Kanzius machine, and after a few years, concluded that it does heal without any extra agent like metal nanoparticle. But that machine is NOT available to any cancer patient! A private company now owns it and has taken it off the market, for reasons you can guess.
Luckily, RF currents can be produced at multiple radio frequencies, including in CB radio range. Thus cancer patients can benefit from this protocol of GEIPE therapy once parameters are standardized.
Why this may be the most scientific cancer treatment
On May 12, 2016 in New York Times, one of the fathers of molecular biology, Dr. James Watson (of Watson-Crick DNA double helix fame) who spent 4 decades exploring genetic aspects of cancer, stated:
Locating the genes that cause cancer has been "remarkably unhelpful"... If he were going into cancer research today, he would study biochemistry rather than molecular biology. [highlights added]And according to biochemistry,
- All transformations in a biological cell are mediated by one or more enzymes.
- For cell growth, the most critical enzyme is Ribonucleotide Reductase, RnR, since it controls the rate-limiting step in DNA synthesis. (Various cancer chemo drugs aim to block this enzyme, but with only partial success and much attendant toxicity.)
- This GEIPE therapy disables RnR by biophysical means. It is a non-toxic treatment with high degree of efficacy in both animals and humans.
There is considerable evidence that cancer is initiated
at the active-site of the enzyme RnR. (Dr. Y Yen certainly
thinks so.) Thus by targeting this enzyme, we may be
nipping cancer in the bud.
Please see the published article on this subject:
"Biochemistry – Not Oncogenes – May Demystify and Defeat Cancer" (2023)
The Best Treatment – Available for Skin and Near-skin Cancers
We offer our device for cancers which are at or near the skin surface, in other words visible/palpable cancers – and also include prostate cancer since it is palpable from urologist's way of probing. All these can be non-surgically treated as a home-remedy, though some initial supervision – provided over the Internet – is sometimes needed.
All skin cancer types – be they basal cell, squamous cell, Merkle cell, melanoma or Kaposi sarcoma – are treatable using the device. This scientific treatment is:
- Non-invasive, non-surgical (using surface electrodes)
- Very Affordable; in fact, too low-cost to be offered by oncologists
It is not an exaggeration to say that it is the best skin cancer treatment available, much superior to Mohs surgery. Though entirely scientific, this treatment may be called holistic, complimentary, natural or alternative. As an exception, here too good is true! Please reach us from contact us page.